Stocks That Hit 52-Week Lows On Tuesday
Tuesday's morning session saw 84 companies set new 52-week lows.
Stocks That Hit 52-Week Lows On Monday
During Monday's session, 56 companies made new 52-week lows.
Impel Pharmaceuticals Earlier Announced Streamlining Plan, Including 16% Workforce Reduction, Largely In The R&D Functions, The Company Plans To Reprioritize Spending On Trudhesa (Dihydroergotamine Mesylate) Nasal Spray For Migraine
The plan will halt research and development efforts on INP105 (olanzapine) to address acute agitation and aggression in autism spectrum disorder.
Aligned with this, the Company also announced that Stephen
Wedbush Downgrades Impel Pharmaceuticals to Neutral, Lowers Price Target to $5
Wedbush analyst Laura Chico downgrades Impel Pharmaceuticals (NASDAQ:IMPL) from Outperform to Neutral and lowers the price target from $24 to $5.
Earnings Scheduled For November 14, 2022
Companies Reporting Before The Bell
• Opiant Pharma (NASDAQ:OPNT) is estimated to report quarterly loss at $1.49 per share on revenue of $3.68 million.